Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study

Journal of Hepatology

Volumn 52, Issue 6, 2010, Pages 880-888

  Cucchetti, Alessandro ^a   Piscaglia, Fabio ^a   Grigioni, Antonia D'Errico ^a   Ravaioli, Matteo ^a   Cescon, Matteo ^a   Zanello, Matteo ^a   Grazi, Gian Luca ^a   Golfieri, Rita ^a   Grigioni, Walter Franco ^a   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Artificial neural network; Hepatocellular carcinoma; Liver resection; Liver transplantation; Microscopic vascular invasion; Tumour grade

Indexed keywords

ALPHA FETOPROTEIN;

ACCURACY; ADULT; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER GRADING; CANCER INVASION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC VASCULAR INVASION; PILOT STUDY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MICROVESSELS; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEURAL NETWORKS (COMPUTER); PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; RECURRENCE; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 77952430837     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.12.037     Document Type: Article

References (39)

1. El-Serag H.B., Davila J.A., Petersen N.J., and McGlynn K.A. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139 (2003) 817-823
2. Thompson C.J., Rogers G., Hewson P., Wright D., Anderson R., Cramp M., et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess 11 (2007) 1-206
3. Wayne J.D., Lauwers G.Y., Ikai I., Doherty D.A., Belghiti J., Yamaoka Y., et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 235 (2002) 722-730
4. Regimbeau J.M., Abdalla E.K., Vauthey J.N., Lauwers G.Y., Durand F., Nagorney D.M., et al. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol 85 (2004) 36-41
5. Jonas S., Bechstein W.O., Steinmüller T., Herrmann M., Radke C., Berg T., et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33 (2001) 1080-1086
6. Klintmalm G.B. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumour characteristics on outcome. Ann Surg 228 (1998) 479-490
7. Poon R.T., Fan S.T., Ng I.O., Lo C.M., Liu C.L., and Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89 (2000) 500-507
8. Portolani N., Coniglio A., Ghidoni S., Giovanelli M., Benetti A., Tiberio G.A., et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243 (2006) 229-235
9. Cucchetti A., Piscaglia F., Caturelli E., Benvegnù L., Vivarelli M., Ercolani G., et al. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol 16 (2009) 413-422
10. Bolondi L., Sofia S., Siringo S., Gaiani S., Casali A., Zironi G., et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 48 (2001) 251-259
11. Pawlik T.M., Gleisner A.L., Anders R.A., Assumpcao L., Maley W., and Choti M.A. Preoperative assessment of hepatocellular carcinoma tumour grade using needle biopsy: implications for transplant eligibility. Ann Surg 245 (2007) 435-442
12. Esnaola N.F., Lauwers G.Y., Mirza N.Q., Nagorney D.M., Doherty D., Ikai I., et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 6 (2002) 224-232
13. Pawlik T.M., Delman K.A., Vauthey J.N., Nagorney D.M., Ng I.O., Ikai I., et al. Tumour size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11 (2005) 1086-1092
14. Shirabe K., Itoh S., Yoshizumi T., Soejima Y., Taketomi A., Aishima S., et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 95 (2007) 235-240
15. Kim B.K., Han K.H., Park Y.N., Park M.S., Kim K.S., Choi J.S., et al. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma. J Surg Oncol 97 (2008) 246-252
16. Pawlik T.M., Abdalla E.K., and Vauthey J.N. Liver transplantation for hepatocellular carcinoma: need for a new patient selection strategy. Ann Surg 240 (2004) 923-924
17. Cross S., Harrison R.F., and Kennedy R.L. Introduction to neural networks. Lancet 346 (1995) 1075-1079
18. Baxt W.G. Application of artificial neural network to clinical medicine. Lancet 346 (1995) 1135-1138
19. Cucchetti A., Vivarelli M., Heaton N.D., Phillips S., Piscaglia F., Bolondi L., et al. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut 56 (2007) 253-258
20. Piscaglia F., Cucchetti A., Benlloch S., Vivarelli M., Berenguer J., Bolondi L., et al. Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors. Eur J Gastroenterol Hepatol 18 (2006) 1255-1261
21. Forsstrom J.J., and Dalton K.J. Artificial neural networks for decision support in clinical medicine. Ann Med 27 (1995) 509-517
22. Del Gaudio M., Ercolani G., Ravaioli M., Cescon M., Lauro A., Vivarelli M., et al. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant 8 (2008) 1177-1185
23. Ravaioli M., Ercolani G., Cescon M., Vetrone G., Voci C., Grigioni W.F., et al. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver transpl 10 (2004) 1195-1202
24. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
25. Edmondson H.A., and Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7 (1954) 462-503
26. Nzeako U.C., Goodman Z.D., and Ishak K.G. Comparison of tumour pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer 76 (1995) 579-588
27. Vauthey J.N., Lauwers G.Y., Esnaola N.F., Do K.A., Belghiti J., Mirza N., et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 20 (2002) 1527-1536
28. Rumelhart D.E., Hinton G.E., and Williams R.L. Learning representation by back-propagating errors. Nature 323 (1986) 533-536
29. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
30. Cillo U., Vitale A., Bassanello M., Boccagni P., Brolese A., Zanus G., et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 239 (2004) 150-159
31. Bruix J., and Llovet J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35 (2002) 519-524
32. Yao F.Y., Ferrel L., Bass N.M., Watson J.J., Bacchetti P., Venook A., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumour size limits does not adversely impact survival. Hepatology 33 (2001) 1394-1403
33. Todo S., and Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 240 (2004) 451-461
34. Marsh J.W., Dvorchik I., Subotin M., Balan V., Rakela J., Popechitelev E.P., et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 26 (1997) 444-450
35. Marsh J.W., and Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure?. Liver Transpl 9 (2003) 693-696
36. Dumortier J., Lombard-Bohas C., Valette P.J., Boillot O., Scoazec J.Y., Berger F., et al. Needle tract recurrence of hepatocellular carcinoma after liver transplantation. Gut 47 (2000) 301
37. Kim S.H., Lim H.K., Lee W.J., Cho J.M., and Jang H.J. Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 25 (2000) 246-250
38. Durand F., Regimbeau J.M., Belghiti J., Sauvanet A., Vilgrain V., Terris B., et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 35 (2001) 254-258
39. Mazzaferro V., Llovet J.M., Miceli R., Bhoori S., Schiavo M., Mariani L., et al. Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10 (2009) 35-43